Photocure partners with Clinigen on Named Patient Program broadening Access to Hexvix/Cysview (hexaminolevulinate HCl)

The Quick Take
OSLO, Norway, Nov. 18, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) announces today that it entered into an agreement with Clinigen, for global supply of Hexvix under a Named Patient Program (NPP) starting in 40+ markets in which the product is not yet approved or commercially available...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
CELLCOM ISRAEL LTD. Announcement of An Annual General Meeting of The Shareholders of The Company
NETANYA, Israel, Nov. 18, 2026 /PRNewswire/ -- Cellcom Israel Ltd. (TASE: CEL) (the "Company") announces that the Meeting will convene on Thursday, December…
Business
Denali Therapeutics at Jefferies Global Healthcare Conference: launch gains
Business
CytomX at Jefferies Global Healthcare Conference: EpCAM bet gains traction
Business
Annonce des lauréates de la 23e édition des Stevie® Awards récompensant les femmes en affaires
Des entreprises détenues par des femmes et des professionnelles ont été honorées lors d'une cérémonie de remise de prix à New York FAIRFAX, Virginie, 18…
